Fri, Aug 29, 2014, 3:29 PM EDT - U.S. Markets close in 31 mins.

Recent

% | $
Quotes you view appear here for quick access.

Allergan Inc. Message Board

  • insect_insight insect_insight Dec 17, 2012 4:02 PM Flag

    revised near term AGN target price....$130-$135

     

    The extremely strong close, blasting through former 93.00 resistance, and converting that level into new solid SUPPORT, was far more powerful than I expected.

    That means a series of GAP UP moves is now coming to this radically undervalued AGN beauty, sooner than later

    This topic is deleted.
    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I & I, you are one of quite a few pounding the table on AGN with bullish, outperform and exuberant forward looking ratings.
      What is the timeline for your target price?
      And please elaborate as to whether your analysis covers the recent arrival of Valeant Pharm.(VRX), into a mano-a-mano with AGN in the aesthetic and dermatology sector.

      I view this competition as a huge positive and should result in an expansion and build out of the sector over the next 5 to 10 years.
      With AGN, being the 800 LB gorilla, it should benefit the most, however; VRX should also benefit and the net result should be a win-win.
      Does your attached assessment baked in this scenario?
      Please elaborate?

    • I & I, you are one of quite a few pounding the table on AGN with bullish, outperform and exuberant forward looking ratings.
      What is the timeline for your target price?
      And please elaborate as to whether your analysis covers the recent arrival of Valeant Pharm.(VRX), into a mano-a-mano with AGN in the aesthetic and dermatology sector.

      I view this competition as a huge positive and should result in an expansion and build out of the sector over the next 5 to 10 years.
      With AGN, being the 800 LB gorilla, it should benefit the most, however; VRX should also benefit and the net result should be a win-win.
      Does your attached assessment baked in this scenario?
      Please elaborate?

    • I & I, you are one of quite a few pounding the table on AGN with bulish, outperform and exuberant forward looking ratings.
      What is the timeline for your target price?
      And please elaborate as to whether your analysis covers the recent arrival of Valeant Pharm.(VRX), into a mano-a-mano with AGN in the aesthetic and dermatology sector.

      I view this competition as a huge positive and should result in an expansion and build out of the sector over the next 5 to 10 years.
      With AGN, being the 800 LB gorilla, it should benefit the most, however; VRX should also benefit and the net result should be a win-win.
      Does your attached assessment baked in this scenario?
      Please elaborate?

 
AGN
162.85+0.74(+0.46%)3:29 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.